Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 123

Biotechnology

The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government
Biotechnology | Therapeutics | Vaccine

The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government

On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…

Read More The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands GovernmentContinue

The CDC responded to a multi-state outbreak of salmonella infections associated with raw tuna
Biotechnology | CDC | Infectious Disease | Marine Science | Therapeutics

The CDC responded to a multi-state outbreak of salmonella infections associated with raw tuna

On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…

Read More The CDC responded to a multi-state outbreak of salmonella infections associated with raw tunaContinue

Rocky Mountain Biological Laboratory announced $10 million legacy campaign
Biotechnology | Environmental | Non-Profit Research

Rocky Mountain Biological Laboratory announced $10 million legacy campaign

On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…

Read More Rocky Mountain Biological Laboratory announced $10 million legacy campaignContinue

FDA approved HibMenCY vaccine for infants
Biotechnology | Disease | FDA | Vaccine

FDA approved HibMenCY vaccine for infants

On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…

Read More FDA approved HibMenCY vaccine for infantsContinue

The European Region of the world was certified as polio-free
Biotechnology | Infectious Disease | Polio | Vaccine | WHO

The European Region of the world was certified as polio-free

On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…

Read More The European Region of the world was certified as polio-freeContinue

Scientists decoded genome of bonobo
Biotechnology | Diagnostics | Genomics | Infectious Disease | Therapeutics | Veterinary

Scientists decoded genome of bonobo

On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…

Read More Scientists decoded genome of bonoboContinue

The Human Microbiome Project milestone announced
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics

The Human Microbiome Project milestone announced

On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….

Read More The Human Microbiome Project milestone announcedContinue

Genentech drug Perjeta (pertuzumab) was approved
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health

Genentech drug Perjeta (pertuzumab) was approved

On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…

Read More Genentech drug Perjeta (pertuzumab) was approvedContinue

Scientists decoded genome of Chagas disease
Biotechnology | Genomics | Infectious Disease | Therapeutics

Scientists decoded genome of Chagas disease

On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…

Read More Scientists decoded genome of Chagas diseaseContinue

U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”
Biotechnology | Infectious Disease | Life Science History | NIH | Non-Profit Research | Vaccine

U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”

On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…

Read More U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”Continue

First patent application granted for CRISPR-Cas9 gene editing in all environments
Biotechnology | CRISPR | Genomics | NIH | Non-Profit Research | Therapeutics

First patent application granted for CRISPR-Cas9 gene editing in all environments

On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…

Read More First patent application granted for CRISPR-Cas9 gene editing in all environmentsContinue

AZBio led a cross industry coalition to amend Arizona’s Open Records Law
Biotechnology | Non-Profit Research

AZBio led a cross industry coalition to amend Arizona’s Open Records Law

May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…

Read More AZBio led a cross industry coalition to amend Arizona’s Open Records LawContinue

FDA approved orphan drug Elelyso to treat a form of Gaucher disease
Biotechnology | Disease | FDA | Therapeutics

FDA approved orphan drug Elelyso to treat a form of Gaucher disease

On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…

Read More FDA approved orphan drug Elelyso to treat a form of Gaucher diseaseContinue

Hologic acquired Gen-Probe for $37 billion
Biotechnology | Diagnostics | Disease | Women's Health

Hologic acquired Gen-Probe for $37 billion

On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…

Read More Hologic acquired Gen-Probe for $37 billionContinue

Treatment outcomes in black and white children with cancer was published
Biotechnology | Diagnostics | Oncology | Therapeutics

Treatment outcomes in black and white children with cancer was published

On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…

Read More Treatment outcomes in black and white children with cancer was publishedContinue

The Golden Goose Award was founded
Biotechnology | Diagnostics | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics | U.S. Congress

The Golden Goose Award was founded

On Apr. 25, 2012, U.S. Representatives Jim Cooper (D-Tenn.), Charlie Dent (R-Pa.), and Robert J. Dold (R-Ill.) joined…

Read More The Golden Goose Award was foundedContinue

The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in California
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Neurology | USDA

The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in California

On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…

Read More The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in CaliforniaContinue

Washington State Secretary of Health declared a pertussis epidemic
Biotechnology | Infectious Disease | Vaccine

Washington State Secretary of Health declared a pertussis epidemic

On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By June 16, the…

Read More Washington State Secretary of Health declared a pertussis epidemicContinue

Report to the nation finds continuing declines in cancer death rates since the early 1990s
Biotechnology | CDC | Oncology | Therapeutics

Report to the nation finds continuing declines in cancer death rates since the early 1990s

On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…

Read More Report to the nation finds continuing declines in cancer death rates since the early 1990sContinue

OHSU’s Oregon National Primate Research Center opened dedicated lab space
Biotechnology | Medicine | Therapeutics

OHSU’s Oregon National Primate Research Center opened dedicated lab space

On Mar. 27, 2012, the Oregon National Primate Research Center at OHSU dedicated a new home for its…

Read More OHSU’s Oregon National Primate Research Center opened dedicated lab spaceContinue

The Priestley Medal was awarded to Robert S. Langer
Biotechnology | Chemical | Therapeutics

The Priestley Medal was awarded to Robert S. Langer

On Mar. 27, 2012, the American Chemical Society awarded the Priestley Medal to Robert S. Langer “to recognize…

Read More The Priestley Medal was awarded to Robert S. LangerContinue

Single antibody shrinks variety of human tumors transplanted into mice, study showed
Biotechnology | Oncology | Therapeutics

Single antibody shrinks variety of human tumors transplanted into mice, study showed

On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…

Read More Single antibody shrinks variety of human tumors transplanted into mice, study showedContinue

OHSU-led consortium awarded $21 million grant to study alcoholism, stress
Biotechnology | Neurology | Therapeutics

OHSU-led consortium awarded $21 million grant to study alcoholism, stress

On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…

Read More OHSU-led consortium awarded $21 million grant to study alcoholism, stressContinue

Draft sequence of the gorilla genome was published
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics

Draft sequence of the gorilla genome was published

On Mar. 8, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…

Read More Draft sequence of the gorilla genome was publishedContinue

Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building

On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…

Read More Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor buildingContinue

Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
Biotechnology | Diagnostics | Influenza | Non-Profit Research | Therapeutics | Vaccine

Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu

On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…

Read More Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the fluContinue

The FDA approved Korlym for patients with endogenous Cushing’s syndrome
Biotechnology | Disease | FDA | Therapeutics

The FDA approved Korlym for patients with endogenous Cushing’s syndrome

On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…

Read More The FDA approved Korlym for patients with endogenous Cushing’s syndromeContinue

Entire genome of extinct Denisovan human decoded from fossil
Biotechnology | Genomics | Life Science History | Non-Profit Research

Entire genome of extinct Denisovan human decoded from fossil

On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…

Read More Entire genome of extinct Denisovan human decoded from fossilContinue

The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
Biotechnology | FDA | Non-Profit Research | Oncology | Therapeutics

The FDA approved Gleevec for Five Rare, Life-Threatening Disorders

On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…

Read More The FDA approved Gleevec for Five Rare, Life-Threatening DisordersContinue

The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
Biotechnology | FDA | Therapeutics

The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis

On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…

Read More The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosisContinue

Page navigation

Previous PagePrevious 1 … 121 122 123 124 125 … 171 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search